In vitro anti-Leishmanial activity of compounds in current clinical use for unrelated diseases.
Drugs in current clinical use were tested for anti-Leishmania activity using an in vitro infected macrophage assay. Out of almost 400 compounds tested, over 100 were active. The most active compounds showed ED50 values below 1 microM concentration. It is concluded that the active compounds should receive testing in the in vivo system. In addition they will act as lead compounds for further synthetic programmes.